Welcome to LookChem.com Sign In|Join Free
  • or
4-(3,4-Difluorophenyl)-1,2,3,4-tetrahydro-6-methyl-2-oxo-5-pyrimidinecarboxylic acid is a pyrimidine carboxylic acid derivative featuring a 6-membered pyrimidine-2,4(1H,3H)-dione ring with a 3,4-difluorophenyl group at the 4th position and a methyl group at the 6th position. This chemical compound possesses potential biological activity and is under investigation for its pharmaceutical applications due to its unique molecular structure, making it a promising candidate for drug development and medicinal chemistry.

356566-58-0

Post Buying Request

356566-58-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

356566-58-0 Usage

Uses

Used in Pharmaceutical Industry:
4-(3,4-Difluorophenyl)-1,2,3,4-tetrahydro-6-methyl-2-oxo-5-pyrimidinecarboxylic acid is used as a pharmaceutical intermediate for the development of new drugs. Its unique molecular structure and potential biological activity make it a valuable compound for further research and synthesis of therapeutic agents.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 4-(3,4-Difluorophenyl)-1,2,3,4-tetrahydro-6-methyl-2-oxo-5-pyrimidinecarboxylic acid serves as a key building block for the design and synthesis of novel compounds with potential therapeutic properties. Its structural features allow for the exploration of various chemical modifications to enhance its biological activity and selectivity.
Used in Drug Discovery:
4-(3,4-Difluorophenyl)-1,2,3,4-tetrahydro-6-methyl-2-oxo-5-pyrimidinecarboxylic acid is utilized in drug discovery processes to identify new lead compounds with potential therapeutic effects. Its unique chemical structure provides a foundation for optimizing pharmacokinetic and pharmacodynamic properties, leading to the development of innovative treatments for various diseases.
Used in Biochemical Studies:
In biochemical research, 4-(3,4-Difluorophenyl)-1,2,3,4-tetrahydro-6-methyl-2-oxo-5-pyrimidinecarboxylic acid is employed as a tool compound to study the interactions between small molecules and biological targets. Its potential biological activity allows researchers to investigate its binding affinity, selectivity, and mechanism of action, contributing to a better understanding of molecular recognition and signaling pathways.

Check Digit Verification of cas no

The CAS Registry Mumber 356566-58-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,5,6,5,6 and 6 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 356566-58:
(8*3)+(7*5)+(6*6)+(5*5)+(4*6)+(3*6)+(2*5)+(1*8)=180
180 % 10 = 0
So 356566-58-0 is a valid CAS Registry Number.

356566-58-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(3,4-difluorophenyl)-6-methyl-2-oxo-3,4-dihydro-1H-pyrimidine-5-carboxylic acid

1.2 Other means of identification

Product number -
Other names A6226

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:356566-58-0 SDS

356566-58-0Downstream Products

356566-58-0Relevant academic research and scientific papers

Solid-Phase Synthesis of Dihydropyrimidones via N-Acyliminium Ion-Based α-Ureidoalkylations

Valverde, Maria Garcia,Dallinger, Doris,Kappe, C. Oliver

, p. 741 - 744 (2007/10/03)

The synthesis of 4-aryl-2-(thioxo)oxo-3,4-dihydropyrimidine-5-carboxylic acids is reported using two orthogonal solid-phase variations of the Biginelli condensation. In the first method, polymer-bound β-ketoesters are treated with aromatic aldehydes and urea under acidic conditions. The transient N-acyliminium ion that is initially formed from the aldehyde and urea precursors, is then intercepted by the resin-bound β-ketoesters. In an alternative approach, resin-bound β-ketoesters are condensed with aldehydes and O-methylisourea under basic conditions. Both orthogonal condensation procedures provide fair to excellent overall yields of the desired target structures.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 356566-58-0